Capital Call Facility

A capital call facility is a revolving credit line extended by banks to a private equity fund, allowing the fund to borrow cash immediately against future LP capital commitments. Rather than waiting for limited partners to wire funds after a capital call, the GP draws against the facility, deploys the cash into investments or operations, and repays the bank as committed capital arrives—compressing the deployment timeline and inflating early-stage returns.

Why GPs use them (and why banks like them)

The gap between a GP’s desire to deploy capital and an LP’s willingness to wire it can be weeks or months. A capital call facility collapses that friction. The GP calls capital on Monday; the bank credit line lends by Tuesday; the GP buys an asset on Wednesday; LPs wire cash over the following 10 business days; the bank is repaid.

From the lender’s perspective, a capital call facility is nearly risk-free. The loan is secured by pledges of LP commitments—typically from institutions with strong credit, like pension funds or endowments. If an LP defaults on a commitment, the bank has contractual claim to the defaulted capital or can accelerate repayment demands. Default rates on committed capital are historically near zero.

Banks price these facilities tightly because they’re short-duration, low-loss instruments. A 200-basis-point margin above SOFR is common for strong funds; weaker or smaller funds pay 250–300 basis points.

The IRR trick (and why it works)

Capital call facilities create a genuine but often overlooked boost to early fund returns. Suppose a fund closes a $500 million commitment and deploys $100 million into a purchase on day two. Without the facility, the GP holds cash for weeks and earns nothing; IRR suffers. With the facility, the GP deploys immediately, the asset begins accruing value or cash flow, and the early numerator of the return calculation jumps higher.

Over a five-year fund, this timing advantage can add 50–150 basis points to the fund’s gross IRR, depending on deployment speed and market conditions. The cost—a few hundred basis points of interest for a few weeks—is trivial compared to the return lift.

This is not fraudulent, but it is an optical advantage. Net returns to LPs (after the bank interest gets paid) still improve modestly, because the capital is put to work faster. But the effect is real only if the deployed capital actually earns competitive returns; if the GP is a poor investor, the facility has just financed a bad decision sooner.

Terms and covenants

A typical capital call facility includes:

• Commitment size: Usually 50–75% of total LP commitments, sometimes up to 100%. A $1 billion fund might secure a $600 million facility.
• Accordion feature: Many deals allow the GP to expand the facility as new capital is committed (e.g., during a follow-on fund raise).
• Quarterly reporting: The lender receives updates on capital deployed, LP contribution rates, and unrealised asset valuations.
• Materiality carve-outs: GPs can violate certain covenants during market stress if the fund remains solvent.
• Mandatory prepayment: As LPs wire in capital, the facility is repaid automatically; no discretion needed.

The agreement typically requires the GP to maintain the facility until the fund enters its exit phase (usually years 4–7 of a 10-year fund). Once the fund has stabilized its portfolio and begun liquidating, the facility is no longer essential and is cancelled.

Risks to GPs and LPs

For GPs, the main risk is over-leverage. If deployment is slower than expected—say, due to market downturns or tough M&A negotiations—the facility sits borrowed while interest accrues and the GP must pay it down with capital that was meant for investments. This can force the GP into poor exit timing or asset sales to service the debt.

For LPs, the facility introduces a small hidden leverage cost. The interest expense reduces fund-level cash flows, eating into net returns by a basis point or two. If LPs expected a certain distribution schedule, the facility can delay interim cashouts. And if a borrowing-stage downturn coincides with slow LP capital calls, the GP might struggle to repay the bank—a tail-risk scenario, but not impossible in a 2008-scale liquidity freeze.

Regulators and institutional LPs also watch capital call facilities carefully. Some investors contractually restrict their GPs from using them, viewing the leverage as unnecessary risk. Others embrace them as efficient capital management.

When the market tightens

During credit crises, banks retreat from capital call facilities rapidly. In 2008 and again in the early pandemic (March 2020), many GPs found their facilities revoked or repriced dramatically upward. This forced longer cash-on-hand periods and slowed deployment—a painful reminder that a convenient loan isn’t guaranteed.

Sophisticated GPs now treat capital call facilities as optional optionality, not a necessity. They structure deals to work with or without the facility, so a sudden credit freeze doesn’t derail the fund’s strategy.

See also